Want to see CANN full AI Analyst Report?
CANN Stock Chart & Stats
$0.04
<$0.01(8.79%)
At close: 4:00 PM EST
$0.04
<$0.01(8.79%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.06
Previous CloseN/A
Volume18.50K
Average Volume (3M)152.58K
Market Cap
$2.43M
Enterprise Value$23.31M
Total Cash (Recent Filing)$214.33K
Total Debt (Recent Filing)$17.31M
Price to Earnings (P/E)―
Beta0.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding110,934,220
10 Day Avg. Volume152,002
30 Day Avg. Volume152,580
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-0.99
Price to Sales (P/S)0.33
P/FCF Ratio-2.78
Enterprise Value/Market Cap9.60
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit4.01
Enterprise Value/Ebitda27.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operating Profitability ImprovingEBIT turning positive in 2025 and sustained gross profit demonstrate material improvement in core unit economics. Durable margin recovery reduces cash burn risk, supports reinvestment or debt reduction, and increases the probability that the business can reach sustained profitability if revenue stabilizes.
Narrowing Free Cash Flow LossesA sharp narrowing of free cash flow shortfalls signals improving cash conversion and operational discipline. Sustained improvement lowers near-term external funding needs, strengthens liquidity dynamics over months, and provides management more flexibility to prioritize deleveraging or targeted growth investments.
Sizeable Asset BaseA sizable asset base offers tangible resources that can support operations, collateralize financings, or be monetized if needed. Over a multi-month horizon this provides options for restructuring capital, securing bridge financing, or extracting value to shore up the balance sheet if operating trends continue improving.
Bears Say
Negative Shareholder EquityNegative equity is a structural weakness that impairs financial flexibility and increases refinancing risk. It restricts access to conventional capital, can trigger covenant or counterparty issues, and typically forces dilutive issuances or costly debt solutions, affecting long-term solvency and strategy execution.
Contracting Revenue TrendA multi-year revenue contraction undermines scale economics, reduces operating leverage, and pressures margins despite cost improvements. Persistent top-line declines make it harder to sustain recent EBIT gains and increase the likelihood that profitability gains are temporary without a durable recovery in demand or market share.
Persistent Negative Cash FlowOngoing negative operating and free cash flow mean the business remains reliant on external capital to fund operations. This structural cash deficit raises dilution or debt risk, limits strategic optionality, and can force short-term financing decisions that harm long-term shareholder value if negative cash generation persists.
General Cannabis News
CANN FAQ
What was General Cannabis Corp’s price range in the past 12 months?
General Cannabis Corp lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
What is General Cannabis Corp’s market cap?
General Cannabis Corp’s market cap is $2.43M.
When is General Cannabis Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were General Cannabis Corp’s earnings last quarter?
Currently, no data Available
Is General Cannabis Corp overvalued?
According to Wall Street analysts General Cannabis Corp’s price is currently Overvalued.
Does General Cannabis Corp pay dividends?
General Cannabis Corp does not currently pay dividends.
What is General Cannabis Corp’s EPS estimate?
General Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does General Cannabis Corp have?
General Cannabis Corp has 110,934,220 shares outstanding.
What happened to General Cannabis Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of General Cannabis Corp?
Currently, no hedge funds are holding shares in CANN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
General Cannabis Corp
Denver, Colorado-based Trees Corporation, founded in 2013, specializes in delivering products and services to both the regulated cannabis sector and general consumers throughout the United States. Its business activities are organized into distinct retail and cultivation divisions. The company's facilities include a 17,000 square foot light-deprivation greenhouse for cultivation, a cannabis dispensary located in Englewood, Colorado, and two additional retail outlets in Portland, Oregon. Formerly known as General Cannabis Corp., the company rebranded to Trees Corporation in June 2022.
Technical Analysis
cbdMD
―
Aquestive Therapeutics
―
IM Cannabis Corp
―
―
Incannex Healthcare Limited Sponsored ADR
―